<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3-pharmaceutics-13-00379">
 <label>3.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Scuteri</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Rombola</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Tridico</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Mizoguchi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Watanabe</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sakurada</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sakurada</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Corasaniti</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Bagetta</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Morrone</surname>
    <given-names>L.A.</given-names>
   </name>
  </person-group>
  <article-title>Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs</article-title>
  <source>Curr. Med. Chem.</source>
  <year>2019</year>
  <volume>26</volume>
  <fpage>3764</fpage>
  <lpage>3774</lpage>
  <pub-id pub-id-type="doi">10.2174/0929867325666180307115546</pub-id>
  <?supplied-pmid 29521195?>
  <pub-id pub-id-type="pmid">29521195</pub-id>
 </element-citation>
</ref>
